MSB 3.21% $1.13 mesoblast limited

2023 The Final Countdown, page-2294

  1. 5,838 Posts.
    lightbulb Created with Sketch. 2110
    He was interested enough in the jacc article to do a podcast summarizing the article.

    https://www.jacc.org/do/10.1016/podcast-jacc-81-9-1/full/

    https://hotcopper.com.au/data/attachments/5445/5445870-8b2dde636d3400e5eff2ae48311ebc37.jpg


    "But the interesting data is next. Mesenchymal precursor cells decrease the time to first event for myocardial infarction or a stroke only in patients with a baseline inflammatory state defined as a high sensitive C-reactive protein of equal or more than 2 milligrams per liter. And let's be more specific: mesenchymal precursor cells, decrease the risk of myocardial infarction or stroke by 58 percent. And the risk of the three-point major adverse cardiovascular events by 28 percent. And in patients with significant inflammation, with a C reactive protein of equal or more than 2 milligrams per liter, the decrease in myocardial infarction was by 75% and for stroke by 38 percent."
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.